Oct 05, 2021 / 12:00PM GMT
Geulah Livshits - Chardan Capital Markets LLC - Senior Research Analyst
Good morning and thank you, everyone, for attending the second day of our 5th Annual Chardan Genetic Medicines Conference. I'm Geulah Livshits, a biotech analyst at Chardan and our compliance team has asked us to read the following message which is effective for the whole conference.
The ideas and recommendations presented here are solely those of the presenter and not Chardan. And the presenters have been advised not to discuss any confidential or material non-public information. And additionally, any KOL speaking may have investments or other interests in the names that they discuss.
So, it is now my pleasure to introduce you to our first guest of the day, John Evans, Chief Executive Officer of Beam Therapeutics. John, thank you so much for joining us today.
John Evans - Beam Therapeutics Inc. - CEO and Board Member
It's great to be here. Thanks for having me.
Geulah Livshits - Chardan Capital Markets LLC - Senior Research Analyst
Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers